当前位置：   首页 > 需求大厅

各位智友：本人因检测需要，求分享欧洲药典10.0检测 General Chapters部分。应包括以下内容 2.2.32. Loss on drying 2.4.16. Total ash 2.8.1 Ash insoluble in hydrochloric acid 2.8.2 FOREIGN MATTER 2.2.13 WATER 2.8.4 SWELLING INDEX 2.8.15 BITTERNESS VALUE Appendix XI B1. Ethanol-soluble Extractive Appendix XI B2. Water-soluble Extractive   [更多]

本人由于研发需要，现想求购全套中药材生产基地信息，如果可以提供全套信息，价格面议，如果可以提供具体品种的中国种植基地信息，通过验证齐全且真实的，每个品种可以获得500元信息服务奖励   [更多]

1、P. A. Prajapati and M. M. Patel, “Formulation and in vitro evaluation of atropine sulphate viscous ocular solutions for the mydriatic and cycloplegic effect,” International Journal of Pharmaceutical and Applied Sciences, vol. 1, no. 2, pp. 70–78, 2010. View at Google Scholar 2、D. S. Satya, K. P. Suria, and P. P. Muthu, “Advanced approaches and evaluation of ocular drug delivery system,” American Journal of PharmTech Research, vol. 1, no. 4, pp. 72–92, 2011. View at Google Scholar 3、B. K. Nanjwade, D. B. Sonaje, and F. V. Manvi, “In vitro—in vivo release of ciprofloxacin from ophthalmic formulations,” International Journal of Pharmacy and Biotechnology, vol. 1, no. 1, pp. 23–28, 2011. View at Google Scholar 4、Physicochemical properties and stability of nicorandil By Nagai, Hiroshi; Koizumi, Ikue; Haneda, Masatoshi; Imai, Toshikatsu; Kikuchi, Mineo; Shiba, Motoharu From Iyakuhin Kenkyu (1983), 14(6), 968-79. Language: Japanese, Database: CAPLUS 5、Sobean oil partially hydrogenated 最新德国药典   [更多]

当心血管疾病（心脏病或中风）确诊后，医生会提供治疗建议，但病人的决定是至关重要的。美国心脏协会（AHA）与 以病人为中心的成果研究所（PCORI）合作，网络征集文章。你可以是患者，社区志愿者，家庭成员或任何人，只要你有这方面的亲身经验。根据你的情况来阐述患者的治疗决策是怎样做出的，例如：对寿命的影响，对生活质量的影响，费用，或其他？同时关心过程的完整性，时间，等等。。。 “请于2016年6月9日之前将稿件上传到：https://www.innocentive.com/ar/workspace/challengeDetail?challenge=9933835“ THE CHALLENGE Treatment of heart disease and stroke often requires patients and their families to make many decisions on how to move forward after a cardiac event. Specifically, AHA and PCORI are interested in learning about the “decisional dilemmas” you face – your insights will help guide future research to improve heart health. Based on the input from you and others in the patient and caregiver community, we will identify important concerns and use the perspectives to target research towards what matters most. Despite multiple available treatment options that your physician may describe, you may not always know which option is right/best for you. Tell us about the most difficult decision that you or your family faced when evaluating treatment options for heart disease or stroke. In addition, we would like to understand more about what you considered most important when making this choice or decision. Please pick your top three choices and tell us why they are important to you and your family: Side effects of the treatment Complexity of treatment plan Difficulty in adhering to a treatment Impact on my quality of life Potential to prolong my life Whether the best option for me is selected based on research of people similar to me (personal characteristics such as my age, race and gender) Whether my family history and genetic makeup would influence the effectiveness of a given option Whether a trusted source recommended a specific option The financial impact of the options for me and my family Other:________ Any submission should address the following Submission Requirements: The submission can be from anyone (patient, caregiver, family member, or other)   [更多]

Good Clinical Practice: A Question & Answer Reference Guide 2018 (Electronic)，电子版，要2018年版   [更多]

求购海王药业牛磺酸颗粒（泰瑞宁）微生物检测方法   [更多]

技术要求：我公司为精细化学品专业生产厂家，现闲置一整套手续齐全流水线车间，配备有先进的生产设备和生产技术工人，现公司面向社会寻求技术合作。本公司热忱欢迎社会各界朋友来厂洽谈合作。   [更多]

1、要求提供的信息真实可靠。 2、要求直接提供卖家信息，不接受中介。 3、药智技术转让数据库里面没有的信息。   [更多]

1.产品风险分析报告 2.产品技术要求 3.产品检验报告 4.临床评价资料 5.产品说明书及标签样稿 6.与产品研制、生产有关的质量管理体系文件 7.生产制造信息 8.证明性文件 9.符合性声明   [更多]

需要日本原研二甲硅油乳剂的质量信息和检验报告   [更多]